« prev   random   next »
2   kt1652   ignore (1)   2019 Jan 13, 11:00am   ↑ like (0)   ↓ dislike (0)   quote   flag        

Good news. We will continue to extend human lifespan. Instead of returning to the earth as fertilizer, oldsters will stick around to consume more fossil fuel, cows, buy more shiney plastics, use more Round-up. All great for business.
Don’t take me wrong, I am just as selfish as others. I want to live long and well too.
This is the problem. We will accelerate our timeline to mass extinction. Whee.
3   Ceffer   ignore (1)   2019 Jan 13, 1:45pm   ↑ like (0)   ↓ dislike (0)   quote   flag        

One can not only be an ASSHOLE, one can now be a PERPETUAL ASSHOLE!
4   RC2006   ignore (0)   2019 Jan 13, 5:58pm   ↑ like (0)   ↓ dislike (0)   quote   flag        

Less tunnels if they started callapsing them while in use.
5   FortWayneIndiana   ignore (3)   2019 Jan 13, 6:09pm   ↑ like (0)   ↓ dislike (1)   quote   flag        

Human longetivity is built into us with an expiration date. I wouldn’t expect that to change.
6   tovarichpeter   ignore (2)   2019 Jan 14, 1:24pm   ↑ like (0)   ↓ dislike (0)   quote   flag        

Peter H. Christiansen
Peter H. Christiansen A US biotechnology start-up has entered the race to promote longevity and find treatments for age-related diseases. Life Biosciences will on Monday announce the completion of a $50m funding round — twice its original target — to invest in a range of approaches to extending healthy life.

“We have been operating in stealth mode until now,” said Tristan Edwards, an Australian investment professional who founded the Boston-based company in 2016 with David Sinclair, professor of genetics at Harvard Medical School. “We have undertaken a big land-grab of longevity-related intellectual property and we have pulled together a lot of the world’s longevity scientists.”

Longevity is a rapidly expanding sector of the biotech industry, as scientists learn more about the way biological pathways fail in old age. Investors in Life Biosciences are mainly wealthy individuals and family trusts, reflecting a widespread view that ageing millionaires are keen to put some of their money into longevity research.
7   Heraclitusstudent   ignore (2)   2019 Jan 14, 3:19pm   ↑ like (0)   ↓ dislike (0)   quote   flag        

We're going toward $10 billions human freaking beings soon enough.
Do we really need more self-centered rich who refuse to check-out and let others take their turn?
8   tovarichpeter   ignore (2)   2019 Jan 15, 9:36am   ↑ like (0)   ↓ dislike (0)   quote   flag        

https://endpts.com/harvard-prof-david-sinclair-backs-anti-aging-upstart-life-bio-which-just-raised-50m-for-research/



You can add Life Biosciences to the list of biotech startups looking to make a name for themselves in the burgeoning field of anti-aging drug research.


David Sinclair
The Boston-based biotech — which has close ties to David Sinclair, a Harvard geneticist who’s been involved in a variety of startups — says today that it’s lined up $50 million in B round cash. There’s no word on who exactly is investing in the company, but there’s no shortage of ambition.


Tristan Edwards
“We have undertaken a big land-grab of longevity-related intellectual property and we have pulled together a lot of the world’s longevity scientists,” Life CEO Tristan Edwards told the Financial Times in a preview of the announcement. Edwards co-founded the company alongside Sinclair.

The FT notes that the money is coming from wealthy investors attracted to the longevity field, but also offers no specifics. The report adds that the company valuation is set at an estimated $500 million.

Life’s claim to fame is that it’s pursuing what the team describes as “all 8” pathways involved in aging, which includes some familiar targets ranging from cell senescence to stem cell exhaustion and mitochondria dysfunction related to the body’s battery packs. And they’ve established 6 subsidiary units to go after these targets in a collaborative fashion, with Senolytic going after the old cells that accumulate in our bodies as we grow older.

Edwards is a transplant from Australia, which may help explain why Life just days ago invested $7.5 million in Prana Biotechnology $PRAN, a small Melbourne-based outfit that’s been engaged for years in high-risk neurodegeneration work.

Anti-aging research has looped in a variety of players, from Google’s Calico to Unity and Juvenescence. Others in biotech are targeting aging related diseases, like muscle weakness, but going after specific ailments along the path to longevity.
9   tovarichpeter   ignore (2)   2019 Jan 15, 9:41am   ↑ like (0)   ↓ dislike (0)   quote   flag        

Heraclitusstudent says
We're going toward $10 billions human freaking beings soon enough.
Do we really need more self-centered rich who refuse to check-out and let others take their turn



https://www.fightaging.org/archives/2006/09/overpopulation/

Over population is a myth, not a problem.
10   kt1652   ignore (1)   2019 Jan 15, 10:27am   ↑ like (0)   ↓ dislike (0)   quote   flag        

"Sirens, who's beautiful song lured countless sailors to shipwreck on the rocky island of Anthemoessa"

You dont need to extrapolate, just look at China, India today. Mars is our only option. lol

about   best comments   contact   one year ago   suggestions